Onco-Innovations Limited (NEO:ONCO)
Canada · Delayed Price · Currency is CAD 0.4000
0.00 (0.00%)
Sep 28, 2026, 4:00 PM EST
Onco-Innovations Market Cap
Onco-Innovations has a market cap or net worth of CAD 27.69 million as of September 29, 2026. Its market cap has decreased by -72.12% in one year.
Market Cap
27.69M
Enterprise Value
27.86M
Revenue
90.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.40
ChartMarket Cap Chart
Since November 27, 2024, Onco-Innovations's market cap has decreased from 28.39M to 27.69M, a decrease of -2.46%. That is a compound annual growth rate of -1.35%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 28, 2026 | 27.69M | -63.49% |
| Dec 30, 2025 | 75.84M | 115.86% |
| Dec 31, 2024 | 35.13M | 23.76% |
| Nov 27, 2024 | 28.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 36.46M |
| Resverlogix | 34.43M |
| Thiogenesis Therapeutics | 34.29M |
| Sernova Biotherapeutics | 33.99M |
| Telescope Innovations | 33.95M |
| Defence Therapeutics | 30.32M |
| Lobe Sciences | 25.47M |
| Devonian Health Group | 24.89M |